NCT02270541

Brief Summary

Interventional prospective randomized open blinded end-point (PROBE) single-center clinical trial on the evaluation of the efficacy, safety, feasibility, reliability, and cost-effectiveness of in-ambulance telemedicine for patients with suspicion of acute stroke.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P75+ for not_applicable stroke

Timeline
Completed

Started Nov 2014

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 16, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 21, 2014

Completed
11 days until next milestone

Study Start

First participant enrolled

November 1, 2014

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2017

Completed
Last Updated

March 2, 2016

Status Verified

March 1, 2016

Enrollment Period

1.3 years

First QC Date

October 16, 2014

Last Update Submit

March 1, 2016

Conditions

Keywords

TelemedicinePrehospitalEmergency MedicineStroke

Outcome Measures

Primary Outcomes (1)

  • Call-to-brain imaging time

    Interval between emergency call and imaging of the brain by computed tomography or magnetic resonance imaging in the hospital.

    within 2 hours

Secondary Outcomes (3)

  • Medical events during in-ambulance telemedicine

    within 2 hours

  • Recanalisation therapy

    upto 8 hours

  • Clinical outcome

    upto 12 months

Other Outcomes (2)

  • Mortality

    upto 100 days

  • Adverse event

    upto 12 months

Study Arms (2)

Control

NO INTERVENTION

Standard pre-hospital emergency care by the Paramedic Intervention Team, in accordance with their standing operating procedures.

Telemedicine

EXPERIMENTAL

In-ambulance teleconsultation by a stroke expert aiming to support the Paramedic Intervention Team by focusing on patient identification, obtaining homeostasis (optimal control of blood pressure, blood oxygenation, temperature, heart rate and rhythm, glycemia), assessment of the patient's neurological status, stroke diagnosis, hospital notification, and patient selection for specific stroke treatment.

Other: Telemedicine

Interventions

In-ambulance telemedicine

Telemedicine

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Emergency transportation by the Paramedic Intervention Team of the Universitair Ziekenhuis Brussel
  • Age \>= 18 years
  • Suspicion of acute stroke with symptom onset \< 12 h or unknown, based on any of the symptoms mentioned in the Belgian manual for medical regulation of pre-hospital care: Hemiparesis, Facial asymmetry, Speech disturbance, Sudden, severe headache, or Confusion.

You may not qualify if:

  • Patients for whom in-ambulance telemedicine consultation would delay any diagnostic or therapeutic intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitair Ziekenhuis Brussel

Brussels, Brussels Capital, 1090, Belgium

Location

MeSH Terms

Conditions

Stroke

Interventions

Telemedicine

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Delivery of Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Jacques De Keyser, MD PhD

    Universitair Ziekenhuis Brussel

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD PhD

Study Record Dates

First Submitted

October 16, 2014

First Posted

October 21, 2014

Study Start

November 1, 2014

Primary Completion

February 1, 2016

Study Completion

February 1, 2017

Last Updated

March 2, 2016

Record last verified: 2016-03

Locations